Blue Biofuels, Inc.

OVERVALUEDBIOF · OTC · Basic Materials
BIOF·OTC·Basic Materials
OVERVALUED
Blue Biofuels, Inc.
43.8%downside
MARKET PRICE
$0.14
FAIR PRICE
$0.08
MARGIN
$0.06
UNDERVALUEDFAIROVERVALUED
P/E RATIO
N/A
DIV. YIELD
N/A
ROE
140.9%
MARKET CAP
$43M
FPI
fairpriceindex.com

FAIR PRICE VALUATION

43.8%downside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$0.14

FAIR PRICE

$0.08

MARGIN

$0.06

UNDERVALUEDFAIROVERVALUED

P/E Ratio

N/A

Div. Yield

N/A

ROE

140.9%

Exceptional

Market Cap

$43M

Small-cap

NOW AVAILABLE

Get notified when BIOF's fair price changes

Push notifications when BIOF's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

1.8/ 10

Low debt levels, but below-average fundamental quality and volatile earnings pattern.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$0.06CONSERVATIVE ENTRY
$0.08FAIR PRICE
$0.14MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$0.06

Fair price × 0.80

DISTANCE

55.1%

Price to entry level

At the current price of $0.14, BIOF trades 55.1% above the conservative entry level of $0.06. This entry level represents a 20% margin of safety below the calculated fair price of $0.08 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate BIOF's fair price

Blue Biofuels, Inc.'s fair price of $0.08 is derived from a blended model that combines DCF analysis (50%), relative valuation against Basic Materials peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $0.14, BIOF trades 43.8% above its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting BIOF's risk profile.

RELATIVE · 30%

Comparing BIOF's valuation multiples against Basic Materials peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for BIOF, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate BIOF's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for BIOF.

Explore on Bulios

FAQ

What is the fair price of BIOF?+

Based on our blended model combining DCF analysis (50%), relative valuation against Basic Materials peers (30%), and analyst consensus (20%), the fair price for Blue Biofuels, Inc. is $0.08. At the current market price of $0.14, BIOF trades 43.8% above its calculated fair value.

Is BIOF overvalued or undervalued?+

Blue Biofuels, Inc. is currently overvalued based on our valuation model. The stock trades at $0.14, which is 43.8% above the fair price of $0.08.

What is the margin of safety for BIOF?+

With a 20% margin of safety applied to the fair price of $0.08, the conservative entry level for BIOF is $0.06. At the current market price of $0.14, the stock trades 55.1% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is BIOF's fair price updated?+

We update fair price calculations for BIOF daily after market close. The current fair price of $0.08 incorporates the latest market data and sector multiples.

What factors affect BIOF's fair price calculation?+

BIOF's fair price of $0.08 is derived from DCF analysis (50% weight), relative valuation against Basic Materials peers (30% weight), and analyst consensus (20% weight)., ROE of 140.9%.

Is BIOF a good buy right now?+

At $0.14, BIOF trades 43.8% above our fair value estimate of $0.08. The stock is currently overvalued. ROE stands at 140.9% (exceptional). Fair Price Index provides valuation data — always do your own research before investing.

Does BIOF pay dividends?+

BIOF does not currently pay a dividend.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.